{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:46Z","timestamp":1761986506922,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jaip.2017.08.022","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T22:46:01Z","timestamp":1507934761000},"page":"687-689.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Chromogranin A is not a biomarker of mastocytosis"],"prefix":"10.1016","volume":"6","author":[{"given":"Pahul","family":"Hanjra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chyi-Chia R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Maric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melody","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirsh D.","family":"Komarow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.08.022_bib1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2017.08.022_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2017.08.022_bib3","doi-asserted-by":"crossref","first-page":"e0124912","DOI":"10.1371\/journal.pone.0124912","article-title":"Determination of plasma heparin level improves identification of systemic mast cell activation disease","volume":"10","author":"Vysniauskaite","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2017.08.022_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/edrv-12-2-181","article-title":"Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker","volume":"12","author":"Deftos","year":"1991","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaip.2017.08.022_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2036.1999.00466.x","article-title":"Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study","volume":"13","author":"Sanduleanu","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2017.08.022_bib6","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/bjc.2011.380","article-title":"Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours","volume":"105","author":"Korse","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaip.2017.08.022_bib7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrgastro.2010.152","article-title":"Esomeprazole-induced hyperchromograninemia in the absence of concomitant\u00a0hypergastrinemia","volume":"7","author":"Gori","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2017.08.022_bib8","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1515\/cclm-2016-0083","article-title":"Reference intervals for the Kryptor second-generation chromogranin A assay","volume":"54","author":"Ferraro","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jaip.2017.08.022_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-4-10","article-title":"Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options","volume":"4","author":"Molderings","year":"2011","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.jaip.2017.08.022_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2141.1988.00441.x-i1","article-title":"Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study","volume":"69","author":"Horny","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2017.08.022_bibE1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2017.08.022_bibE2","first-page":"1","article-title":"Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood","volume":"90:IV:7.37","author":"Radinger","year":"2010","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jaip.2017.08.022_bibE3","first-page":"1","article-title":"Measuring mast cell mediator release","volume":"91:IV:7.38","author":"Kuehn","year":"2010","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jaip.2017.08.022_bibE4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/1523-1747.ep12319788","article-title":"Chromogranin A in the mammalian Merkel cell: cellular and subcellular distribution","volume":"93","author":"Hartschuh","year":"1989","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2017.08.022_bibE5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0167-0115(94)90054-X","article-title":"Production and secretion of chromogranin A and pancreastatin by the human pancreatic carcinoma cell line QGP-1N on stimulation with carbachol","volume":"52","author":"Kitayama","year":"1994","journal-title":"Regul Pept"},{"key":"10.1016\/j.jaip.2017.08.022_bibE6","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.4049\/jimmunol.181.7.5024","article-title":"Secretogranin III directs secretory vesicle biogenesis in mast cells in a manner dependent upon interaction with chromogranin A","volume":"181","author":"Prasad","year":"2008","journal-title":"J\u00a0Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817307055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817307055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:14:38Z","timestamp":1761974078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817307055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213219817307055"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.08.022","relation":{},"ISSN":["2213-2198"],"issn-type":[{"type":"print","value":"2213-2198"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromogranin A is not a biomarker of mastocytosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}